Abstract
The escalating global epidemic of type 2 diabetes mellitus has focused attention on the devastating consequences of protracted hyperglycemia. Early and effective intervention to control blood glucose is a fundamental principle of treatment guidelines, requiring assiduous use of current therapies. However, many patients do not achieve or maintain glycemic targets, emphasizing the need for further therapies. This narrative review assesses the available medicinal options to address hyperglycemia and the opportunities to develop novel agents.
| Original language | English |
|---|---|
| Pages (from-to) | 170–184 |
| Number of pages | 15 |
| Journal | Clinical Pharmacology & Therapeutics |
| Volume | 98 |
| Issue number | 2 |
| Early online date | 23 Jun 2015 |
| DOIs | |
| Publication status | Published - 31 Aug 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'The current drug treatment landscape for diabetes and perspectives for the future'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver